{
  "clinicalImpactSubmission": [
    {
      "recordStatus": "novel",
      "localID": "civic.mpid:244",
      "localKey": "civic.eid:655",
      "observedIn": [
        {
          "alleleOrigin": "somatic",
          "affectedStatus": "yes",
          "collectionMethod": "curation"
        }
      ],
      "conditionSet": {
        "condition": [
          {
            "db": "MONDO",
            "id": "0005075"
          }
        ]
      },
      "variantSet": {
        "variant": [
          {
            "chromosomeCoordinates": {
              "assembly": "GRCh37",
              "chromosome": "5",
              "start": 1295228,
              "stop": 1295228,
              "referenceAllele": "G",
              "alternateAllele": "A"
            },
            "gene": [
              {
                "id": 7015
              }
            ]
          }
        ]
      },
      "clinicalImpactClassification": {
        "clinicalImpactClassificationDescription": "Tier I - Strong",
        "assertionTypeForClinicalImpact": "prognostic: poor outcome",
        "comment": "In patients with papillary thyroid cancer harboring both BRAF V600E and the TERT promotor mutation C228T, recurrence-free survival is worse than in patients harboring one of these mutations or no mutations in either gene.",
        "citation": [
          {
            "db": "PubMed",
            "id": "25024077"
          }
        ]
      }
    }
  ]
}
